Endoscopic submucosal dissection (ESD) has been proposed as the gold standard in the
treatment of early gastric cancer because it facilitates a more accurate histological …

The present study was designed to investigate the role and mechanism of action behind the
action of lidocaine in gastric cancer cells. Lidocaine was tested for its potential role in …

Endoscopic submucosal dissection (ESD) is an advanced therapy for early gastric neoplasm
and requires sedation with adequate analgesia. Lidocaine is a short-acting local anesthetic …

Gene therapy is an emerging technique with widespread applications in treatment of
cardiovascular diseases, monogenic disorder, infectious diseases, and especially cancers …

Background Although pain is a common complication of endoscopic submucosal dissection
(ESD), management strategies are inadequate. The aim of this study was to evaluate the …

OBJECTIVE: Epigastric pain management following endoscopic submucosal dissection is
an important consideration. This study aimed to investigate the utility and safety of fentanyl …

Background and study aims: Endoscopic submucosal dissection (ESD) is widely used for
local treatment of gastric neoplasms. Although ESD-related complications such as bleeding …

Background: Postoperative pain is one of the most common complications after gastric
endoscopic submucosal dissection (ESD); however, there have been only a few studies …

Background Endoscopic submucosal dissection (ESD) is a standard treatment for gastric
neoplasia limited to the mucosa without lymph node metastasis. However, there are neither …

Background Endoscopic submucosal dissection (ESD) has been revealed as an effective
treatment of early gastric neoplasm and should be performed under sedation with adequate …